TPMT and acute leukemia: Polymorphisms in genes such as TPMT (e.g., 3A, 3C) and NUDT15 (e.g., rs116855232) are strongly associated with severe myelotoxicity in patients with acute leukemia treated with thiopurines, such as mercaptopurine and thioguanine.